Does CODEINE\PSEUDOEPHEDRINE\TRIPROLIDINE Cause Product use in unapproved indication? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product use in unapproved indication have been filed in association with CODEINE\PSEUDOEPHEDRINE\TRIPROLIDINE. This represents 35.0% of all adverse event reports for CODEINE\PSEUDOEPHEDRINE\TRIPROLIDINE.
7
Reports of Product use in unapproved indication with CODEINE\PSEUDOEPHEDRINE\TRIPROLIDINE
35.0%
of all CODEINE\PSEUDOEPHEDRINE\TRIPROLIDINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Product use in unapproved indication From CODEINE\PSEUDOEPHEDRINE\TRIPROLIDINE?
Of the 7 reports, 5 (71.4%) required hospitalization, and 5 (71.4%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CODEINE\PSEUDOEPHEDRINE\TRIPROLIDINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does CODEINE\PSEUDOEPHEDRINE\TRIPROLIDINE Cause?
Off label use (8)
Product use issue (8)
Drug ineffective (7)
Headache (7)
Joint swelling (7)
Musculoskeletal stiffness (7)
Pain (7)
Pruritus (7)
Drug dependence (5)
Helicobacter infection (5)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)